Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) Return on Sales (2017 - 2025)

Inspire Medical Systems' Return on Sales history spans 9 years, with the latest figure at 0.51% for Q4 2025.

  • For Q4 2025, Return on Sales rose 36.0% year-over-year to 0.51%; the TTM value through Dec 2025 reached 0.16%, up 9.0%, while the annual FY2025 figure was 0.16%, 9.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.51% at Inspire Medical Systems, up from 0.04% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.51% in Q4 2025 and bottomed at 0.4% in Q1 2021.
  • The 5-year median for Return on Sales is 0.04% (2021), against an average of 0.04%.
  • The largest annual shift saw Return on Sales soared 165bps in 2021 before it decreased -7bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.03% in 2021, then skyrocketed by 175bps to 0.02% in 2022, then surged by 236bps to 0.08% in 2023, then soared by 91bps to 0.15% in 2024, then surged by 245bps to 0.51% in 2025.
  • Per Business Quant, the three most recent readings for INSP's Return on Sales are 0.51% (Q4 2025), 0.04% (Q3 2025), and 0.02% (Q2 2025).